Heraeus to roll out Venus Bulk Fill syringes
The precise syringe delivery of Venus Bulk Fill will provide dentists with an easier, faster restorative solution that is more cost effective per restoration than the traditional incremental
Cellares and GenomeFrontier Therapeutics have announced a collaboration to assess automated manufacturing for the latter’s investigational CAR-T cell therapy, GF-CART01, on the Cell Shuttle platform.